Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease-Reference-Cited by-同舟云学术

Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease

Published:2014-09 Issue:10 Volume:64 Page:1005-1014
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Angiolillo Dominick J.,Jakubowski Joseph A.,Ferreiro José Luis,Tello-Montoliu Antonio,Rollini Fabiana,Franchi Francesco,Ueno Masafumi,Darlington Andrew,Desai Bhaloo,Moser Brian A.,Sugidachi Atsuhiro,Guzman Luis A.,Bass Theodore A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference44 articles.

1. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions;Levine;J Am Coll Cardiol,2011

2. 2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

3. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;O'Gara;J Am Coll Cardiol,2013

4. New directions in antiplatelet therapy;Ferreiro;Circ Cardiovasc Interv,2012

5. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives;Angiolillo;J Am Coll Cardiol,2007

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association;Circulation;2024-08-06

2. Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD;JACC: Basic to Translational Science;2024-07

3. Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis;Journal of the Society for Cardiovascular Angiography & Interventions;2024-07

4. Development of a Physiologically Based Pharmacokinetic Population Model for Diabetic Patients and its Application to Understand Disease-drug–drug Interactions;Clinical Pharmacokinetics;2024-05-31

5. METTL3-mediated methylation of CYP2C19 mRNA may aggravate clopidogrel resistance in ischemic stroke patients;Open Medicine;2024-01-01